Kiyotsugu Iede

Higashi-osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Prognostic Significance of Number of Liver Metastases in Patients With Advanced Pancreatic Cancer Receiving Nab-paclitaxel Plus Gemcitabine.

Prognostic Significance of Number of Liver Metastases in Patients With Advanced Pancreatic Cancer Receiving Nab-paclitaxel Plus Gemcitabine.

Journal: Cancer diagnosis & prognosis

Published: May 01, 2026

Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study.

Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study.

Journal: Anticancer research

Published: February 13, 2026

A Case of Gallbladder MALT Lymphoma

A Case of Gallbladder MALT Lymphoma

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Novel "T-Incision" Method With Robotic-Assisted Transabdominal Preperitoneal Repair for Lateral Inguinal Hernia: An Operative Technique (With Video).

Novel "T-Incision" Method With Robotic-Assisted Transabdominal Preperitoneal Repair for Lateral Inguinal Hernia: An Operative Technique (With Video).

Journal: Asian journal of endoscopic surgery

Published: December 25, 2025

Severe Immune-related Adverse Events and Their Effect on Survival in Patients With Advanced Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.

Severe Immune-related Adverse Events and Their Effect on Survival in Patients With Advanced Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.

Journal: Cancer diagnosis & prognosis

Published: September 29, 2025

Clinical Impact of Upfront Dose Reduction of the First Cycle of First-Line Treatments on Safety and Survival in Elderly Patients With Non-Small Cell Lung Cancer.

Clinical Impact of Upfront Dose Reduction of the First Cycle of First-Line Treatments on Safety and Survival in Elderly Patients With Non-Small Cell Lung Cancer.

Journal: Asia-Pacific journal of clinical oncology

Published: June 11, 2025

Poor Performance Status, Diabetes Mellitus, and Statin use are Risk Factors for Decreased Skeletal Muscle Mass During Nab-paclitaxel Plus Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer.

Poor Performance Status, Diabetes Mellitus, and Statin use are Risk Factors for Decreased Skeletal Muscle Mass During Nab-paclitaxel Plus Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer.

Journal: Pancreas

Published: March 04, 2025

Prognostic Significance of ABO Blood Type in Patients with Advanced Pancreatic Cancer Treated with Nab-Paclitaxel Plus Gemcitabine.

Prognostic Significance of ABO Blood Type in Patients with Advanced Pancreatic Cancer Treated with Nab-Paclitaxel Plus Gemcitabine.

Journal: Pancreas

Published: October 17, 2024

Clinical Significance of Increased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine Treatment in Patients With Advanced Pancreatic Cancer.

Clinical Significance of Increased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine Treatment in Patients With Advanced Pancreatic Cancer.

Journal: Pancreas

Published: December 29, 2023

A Case of Laparoscopic Uterine and Vaginal Resection for Local Recurrence after Abdominoperineal Resection for Anal Canal Cancer

A Case of Laparoscopic Uterine and Vaginal Resection for Local Recurrence after Abdominoperineal Resection for Anal Canal Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: March 17, 2023

A Case of Early Appendiceal Adenocarcinoma Coexisting with High-Grade Appendiceal Mucinous Neoplasm

A Case of Early Appendiceal Adenocarcinoma Coexisting with High-Grade Appendiceal Mucinous Neoplasm

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 03, 2023

Do antihypertensive drugs really have antitumor effects? Baseline differences in hypertensive and non-hypertensive patients with advanced pancreatic cancer.

Do antihypertensive drugs really have antitumor effects? Baseline differences in hypertensive and non-hypertensive patients with advanced pancreatic cancer.

Journal: Medicine

Published: July 22, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026